# NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

> **NCT00356954** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 250 (—)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** N-acetylcystein
- **DRUG:** ascorbic acid

## Key facts

- **NCT ID:** NCT00356954
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 250 (—)
- **Last updated:** 2006-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00356954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00356954, "NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00356954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*